Human papillomavirus carcinogenesis: an identity crisis in the retinoblastoma tumor suppressor pathway

Area of Science:

• Virology
• Epigenetics
• Cancer Biology

Background:

• Viruses are obligate intracellular parasites that manipulate host cells for replication and persistence.
• Human papillomaviruses (HPVs) are linked to carcinogenesis by targeting tumor suppressor networks like RB1 and TP53.
• Emerging evidence points to Polycomb group proteins and epigenetic modifications as key early events in viral reprogramming.

Purpose of the Study:

• To explore the role of epigenetic reprogramming in viral persistence and cellular adaptation.
• To investigate the concept of viral-induced cellular "addictions" to specific survival pathways.
• To evaluate the therapeutic potential of targeting these vulnerabilities via synthetic lethality.

Main Methods:

• Review and synthesis of established and recent findings on viral manipulation of host cell machinery.
• Analysis of the interplay between viral infection, epigenetic regulation, and tumor suppressor pathways.
• Conceptual framework development for synthetic lethality as an antiviral strategy.

Main Results:

• Viral infections induce significant epigenetic alterations, leading to rewiring of cellular signaling.
• Cells adapt to viral presence by becoming dependent on specific survival pathways (cellular "addictions").
• RB1 pathway inactivation appears to be a consequence of, rather than a primary driver for, these cellular adaptations.

Conclusions:

• Epigenetic reprogramming is a critical early step in viral adaptation and persistence.
• Targeting virus-induced cellular dependencies offers a novel therapeutic avenue.
• Synthetic lethality strategies hold promise for treating persistent viral infections and associated cancers.